Spyre Therapeutics, Inc. is a biotech company developing new medicines.
Spyre Therapeutics, Inc. (SYRE) is expected to report earnings on Tuesday, November 3, 2026, after the close. Estimated release time 16:05 ET. Consensus EPS estimate is $-0.78.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | Jun 2026 qtr | $-0.76 | $-0.36 | — | $0 |
| 2026-05-05 | Mar 2026 qtr | $-0.66 | $-0.74 | -12.1% | $0 |
| 2026-02-19 | Dec 2025 qtr | $-0.66 | $-0.70 | -6.1% | $90.49M |
| 2025-11-04 | Sep 2025 qtr | $-0.76 | $-0.15 | — | $0 |
| 2025-08-05 | Jun 2025 qtr | $-0.73 | $-0.60 | — | $0 |
| 2025-05-08 | Mar 2025 qtr | $-0.84 | $-0.13 | — | $0 |
| 2025-02-27 | Dec 2024 qtr | $-0.89 | $-0.15 | — | $0 |
| 2024-11-18 | Sep 2024 qtr | — | $-1.36 | — | $0 |
SYRE has beaten consensus EPS in 0 of its last 2 scored quarters.
See SYRE on the live calendar →